menu search

NRSN / NeuroSense: A Hold Ahead Of Phase 2b ALS Data

NeuroSense: A Hold Ahead Of Phase 2b ALS Data
NeuroSense Therapeutics will report Phase 2b trial data for its ALS drug candidate, PrimeC, in Q4 2023. Topline data of this trial may well be the company's most pivotal event since its IPO at the end of 2021. The company is also targeting Alzheimer's and Parkinson's with the same drug candidate under different names. Read More
Posted: Oct 6 2023, 18:51
Author Name: Seeking Alpha
Views: 112223

NRSN News  

NeuroSense: A Hold Ahead Of Phase 2b ALS Data

By Seeking Alpha
October 6, 2023

NeuroSense: A Hold Ahead Of Phase 2b ALS Data

NeuroSense Therapeutics will report Phase 2b trial data for its ALS drug candidate, PrimeC, in Q4 2023. Topline data of this trial may well be the com more_horizontal

Why Is NeuroSense (NRSN) Stock Up 98% Today?

By InvestorPlace
January 19, 2023

Why Is NeuroSense (NRSN) Stock Up 98% Today?

NeuroSense (NASDAQ: NRSN ) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease ( AD ). Th more_horizontal

NeuroSense Therapeutics (NRSN) Stock Pops on Positive ALS Study Results

By InvestorPlace
June 27, 2022

NeuroSense Therapeutics (NRSN) Stock Pops on Positive ALS Study Results

NRSN stock is getting plenty of attention today and a bid to the tune of more than 70% in the wake of positive clinical results. The post NeuroSense T more_horizontal

Neurosense multiplies investor value 3X. Buy the penny stock and wait

By Invezz
March 22, 2022

Neurosense multiplies investor value 3X. Buy the penny stock and wait

Neurosense Therapeutics Ltd (NASDAQ:NRSN) tripled market value in a day. This was after announcing approval by the US Food and Drugs Authority to adva more_horizontal

Why Is NeuroSense Therapeutics (NRSN) Stock Up 300% Today?

By InvestorPlace
March 21, 2022

Why Is NeuroSense Therapeutics (NRSN) Stock Up 300% Today?

A thumbs up from the FDA has NRSN stock surging. Here's what this victory means for NeuroSense and for investors. more_horizontal

Hottest Penny Stocks To Watch as March Comes to an End

By PennyStocks
March 21, 2022

Hottest Penny Stocks To Watch as March Comes to an End

Check these three penny stocks out for your watchlist right now The post Hottest Penny Stocks To Watch as March Comes to an End  appeared first on Pe more_horizontal

Why NeuroSense Shares Are Soaring Today

By Benzinga
March 21, 2022

Why NeuroSense Shares Are Soaring Today

NeuroSense Therapeutics Ltd (NASDAQ: NRSN) shares are soaring Monday after the company announced it received U.S. Food and Drug Administration cle more_horizontal

NeuroSense Therapeutics to Present at BIO CEO & Investor Conference

By PRNewsWire
January 31, 2022

NeuroSense Therapeutics to Present at BIO CEO & Investor Conference

CAMBRIDGE, Mass., Jan. 31, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd. more_horizontal


Search within

Pages Search Results: